Abacavir reverse transcriptase inhibitor
Dolutegravir integrase inhibitor
Lamivudine nucleoside analog reverse transcriptase inhibitors
Abacavir/dolutegravir/lamivudine (trade name Triumeq) is a fixed-dose combination drug for the treatment of HIV/AIDS.
It is a combination of three drugs with different and complementary mechanisms of action: abacavir, a reverse transcriptase inhibitor, dolutegravir an integrase inhibitor, and lamivudine, a nucleoside analog reverse transcriptase inhibitor.